| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |